Press Releases
This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Sep 6, 2022
- Aug 8, 2022
- Jul 5, 2022
- Jul 1, 2022
- May 20, 2022
- May 19, 2022
- May 16, 2022
- May 9, 2022
- Apr 12, 2022
- Apr 8, 2022
- Mar 30, 2022
- Mar 17, 2022
- Mar 16, 2022
- Mar 1, 2022
- Feb 28, 2022
- Feb 4, 2022
- Feb 3, 2022Approval Reinforces Viatris' Steadfast Commitment to Breaking Down Barriers and Expanding Access to Complex Generic Products
- Jan 18, 2022
- Jan 6, 2022
- Dec 29, 2021Decisions reaffirm Viatris' ability to provide patient access to interchangeable Semglee®
- Dec 17, 2021
- Dec 6, 2021
- Dec 1, 2021
- Nov 18, 2021
- Nov 16, 2021Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
